A new solution for measuring and controlling air quality to be displayed at AQE

Air quality monitoring

A new solution for measuring and controlling air quality to be displayed at AQE

03 Sep, 2021

Published over 4 years ago. See the latest and most current information on Air quality monitoring.

Kunak will display their new solution for measuring and controlling air quality pollution consisting of both hardware (Kunak AIR Pro, air quality monitoring station) and software (Kunak Cloud, an advanced web platform for air quality networks and noise levels management).

The Kunak AIR Pro is a new sensor-based air quality monitoring station designed for professionals to monitor what is in the air in real-time. It is designed to solve all the lifecycle challenges of an air quality product, its operation, and maintenance, as well as the need of every environmental project.

Kunak are developers of disruptive air quality and environmental monitoring technology. Kunak are US EPA approved, suppliers of WHO, partners of World Athletics, with devices installed in five continents.

Kunak designs and manufactures environmental instrumentation, sensor networks, wireless monitoring and control systems and operational intelligence that guarantee the correct transmission and exploitation of information and allow it to be integrated into other systems.

They help companies and organisations to reduce costs, control environmental impact and improve management in real-time with greater efficiency and economic benefit.

For more information visit AQE

Latest News

IET 36.3 May

Explore our Digital Edition

Discover the latest news and research

Digital edition

Explore Our Other Sites

Labmate Online
Direct mercury analysis: Weighing the cost and productivity benefits
Explore more Arrow
Pollution Solutions Online
Slurry grant a fossil fuel failure?
Explore more Arrow
Petro Online
Precision by weight: The critical role of gravimetric blending in fuel certification
Explore more Arrow
Chromatography Today
Unlock high-resolution analysis of therapeutic oligonucleotides
Explore more Arrow